Skip to main content

Table 2 Treatment adherence outcomes in all patients with acromegaly receiving octreotide or lanreotide

From: Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis

Treatment N Variable N Mean SE Minimum Maximum
Octreotide 1127 Treatment time (days) 1127 418.5 14.9 0 1819
  Number of injections 1127 10.8 0.4 1 68
  MPR (%) 891 87 4 0.06 30
Lanreotide 181 Treatment time (days) 181 383.8 28.1 0 1454
  Number of injections 181 11.1 0.8 1 49
  MPR (%) 155 85 3 0.12 3.8
  1. Only one injection was logged and used for treatment time calculation
  2. N sample size, SE standard error, MPR medication possession ratio